{"id":"F2023L00175","name":"Statement of Principles concerning chronic obstructive pulmonary disease (Reasonable Hypothesis) (No. 17 of 2023)","slug":"statement-of-principles-concerning-chronic-obstructive-pulmonary-disease-reasonable-hypothesis-no-17","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"in_force","isInForce":true,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":441734,"registerId":"F2023L00175-fast-fetch-1775956962060","compilationNumber":null,"startDate":"2026-04-12","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Statement of Principles concerning chronic obstructive pulmonary disease (Reasonable Hypothesis) (No. 17 of 2023)","content":"---\nmeta-content-style-type: text/css\nmeta-content-type: application/xhtml+xml; charset=utf-8\nmeta-generator: Aspose.Words for .NET 22.10.0\n---\n\n?xml version=\"1.0\" encoding=\"utf-8\" standalone=\"no\"?>\n\n\n\n \n\nStatement of Principles\n\nconcerning\n\nCHRONIC OBSTRUCTIVE PULMONARY DISEASE (Reasonable Hypothesis)\n\n(No. 17 of 2023)\n\nThe Repatriation Medical Authority determines the following Statement of Principles under subsection 196B(2) of the Veterans' Entitlements Act 1986.\n\n \n\nDated 27 February 2023.\n\n \n\n \n\n \n\n \n\n \n\n| The Common Seal of the Repatriation Medical Authority was affixed to this instrument at the direction of:
|\n| --- |\n|
Professor Terence Campbell AM
Chairperson
|\n\n\n \n\n \n\n\nContents\n\n1 Name\n\n2 Commencement\n\n3 Authority\n\n4 Repeal\n\n5 Application\n\n6 Definitions\n\n7 Kind of injury, disease or death to which this Statement of Principles relates\n\n8 Basis for determining the factors\n\n9 Factors that must exist\n\n10 Relationship to service\n\n11 Factors referring to an injury or disease covered by another Statement of Principles\n\nSchedule 1 - Dictionary\n\n1 Definitions\n\n \n\n\n\n\n1 Name\n\nThis is the Statement of Principles concerning chronic obstructive pulmonary disease (Reasonable Hypothesis) (No. 17 of 2023).\n\n2 Commencement\n\n This instrument commences on 27 March 2023.\n\n3 Authority\n\nThis instrument is made under subsection 196B(2) of the Veterans' Entitlements Act 1986.\n\n4 Repeal\n\nThe Statement of Principles concerning chronic obstructive pulmonary disease No. 37 of 2014 (Federal Register of Legislation No. F2014L00472) made under subsections 196B(2) and (8) of the VEA is repealed.\n\n5 Application\n\nThis instrument applies to a claim to which section 120A of the VEA or section 338 of the Military Rehabilitation and Compensation Act 2004 applies.\n\n6 Definitions\n\nThe terms defined in the Schedule 1 - Dictionary have the meaning given when used in this instrument.\n\n7 Kind of injury, disease or death to which this Statement of Principles relates\n\n(1) This Statement of Principles is about chronic obstructive pulmonary disease and death from chronic obstructive pulmonary disease.\n\nMeaning of chronic obstructive pulmonary disease\n\n(2) For the purposes of this Statement of Principles, chronic obstructive pulmonary disease:\n\n(a) means a chronic progressive inflammatory pathology occurring with different proportions of involvement of the airways, lung parenchyma and vasculature; and\n\n(b) includes:\n\n(i) chronic bronchitis;\n\n(ii) emphysema; and\n\n(iii) persistent airflow limitation; and\n\n(c) excludes:\n\n(i) asbestosis;\n\n(ii) asthma;\n\n(iii) bronchiectasis;\n\n(iv) bronchiolitis obliterans;\n\n(v) fibrosing interstitial lung disease and other fibrosing lung disease;\n\n(vi) hypersensitivity pneumonitis (extrinsic allergic alveolitis); and\n\n(vii) surgical, traumatic or localised emphysema.\n\n \n\nNote 1: Symptoms of chronic obstructive pulmonary disease include dyspnoea, cough and the production of phlegm. Chronic bronchitis typically occurs with the presence of a productive cough for at least three months of the year for at least two consecutive years. Emphysema is characterized by the destruction of alveolar septa with the enlargement of alveolar airspaces.\n\nNote 2: persistent airflow limitation is defined in the Schedule 1 – Dictionary.\n\n(3) While chronic obstructive pulmonary disease attracts ICD‑10‑AM codes J41, J42, J43 and J44, in applying this Statement of Principles the meaning of chronic obstructive pulmonary disease is that given in subsection (2).\n\n(4) For subsection (3), a reference to an ICD-10-AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Tenth Edition, effective date of 1 July 2017, copyrighted by the Independent Hospital Pricing Authority, ISBN 978-1-76007-296-4.\n\nDeath from chronic obstructive pulmonary disease\n\n(5) For the purposes of this Statement of Principles, chronic obstructive pulmonary disease, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's chronic obstructive pulmonary disease.\n\nNote: terminal event is defined in the Schedule 1 – Dictionary.\n\n8 Basis for determining the factors\n\nThe Repatriation Medical Authority is of the view that there is sound medical‑scientific evidence that indicates that chronic obstructive pulmonary disease and death from chronic obstructive pulmonary disease can be related to relevant service rendered by veterans, members of Peacekeeping Forces, or members of the Forces under the VEA, or members under the MRCA.\n\nNote: MRCA, relevant service and VEA are defined in the Schedule 1 – Dictionary.\n\n9 Factors that must exist\n\nAt least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting chronic obstructive pulmonary disease or death from chronic obstructive pulmonary disease with the circumstances of a person's relevant service:\n\n(1) having smoked tobacco products:\n\n(a) in an amount of at least 5 pack-years before the clinical onset of chronic obstructive pulmonary disease; and\n\n(b) if smoking has ceased before the clinical onset of chronic obstructive pulmonary disease, then that onset occurred within 20 years of cessation;\n\nNote: one pack-year is defined in the Schedule 1 – Dictionary.\n\n(2) being exposed to second-hand smoke:\n\n(a) for at least 10,000 hours before the clinical onset of chronic obstructive pulmonary disease; and\n\n(b) if exposure to second-hand smoke has ceased before the clinical onset of chronic obstructive pulmonary disease, then that onset occurred within 20 years of cessation;\n\nNote: being exposed to second-hand smoke is defined in the Schedule 1 – Dictionary.\n\n(3) having smoked cannabis:\n\n(a) in an amount of at least 10 joint-years before the clinical onset of chronic obstructive pulmonary disease; and\n\n(b) if smoking has ceased before the clinical onset of chronic obstructive pulmonary disease, then that onset occurred within 20 years of cessation;\n\nNote: joint-years of cannabis is defined in the Schedule 1 – Dictionary. \n\n(4) inhaling smoke from the combustion of polluting fuels in an enclosed space:\n\n(a) for a cumulative period of at least 5,000 hours before the clinical onset of chronic obstructive pulmonary disease; and\n\n(b) if that exposure has ceased, the clinical onset of chronic obstructive pulmonary disease has occurred within 20 years of cessation;\n\nNote: polluting fuels is defined in the Schedule 1 – Dictionary.\n\n(5) inhaling a respiratory tract irritant from the specified list of respiratory tract irritants resulting in:\n\n(a) signs and symptoms of severe acute lower respiratory damage requiring medical attention within 48 hours after exposure; and\n\n(b) the persistence of respiratory symptoms and signs for at least one week after exposure, within the 10 years before the clinical onset of chronic obstructive pulmonary disease;\n\nNote: specified list of respiratory tract irritants is defined in the Schedule 1 – Dictionary.\n\n(6) inhaling vapour, gas, or fumes of a substance from the specified list of substances in an enclosed space:\n\n(a) for a cumulative period of at least 10,000 hours before the clinical onset of chronic obstructive pulmonary disease; and\n\n(b) if that exposure has ceased, the clinical onset of chronic obstructive pulmonary disease has occurred within 20 years of cessation;\n\nNote: specified list of substances is defined in the Schedule 1 – Dictionary.\n\n(7) inhaling vapour, gas, or fumes of a substance from the specified list of substances, in an open environment:\n\n(a) for a cumulative period of at least 20 000 hours before the clinical onset of chronic obstructive pulmonary disease; and\n\n(b) if that exposure has ceased, the clinical onset of chronic obstructive pulmonary disease has occurred within 20 years of cessation;\n\nNote: specified list of substances is defined in the Schedule 1 – Dictionary.\n\n(8) inhaling organic or inorganic dust at a concentration of greater than 5 milligrams per cubic metre:\n\n(a) for a cumulative period of at least 10,000 hours before the clinical onset of chronic obstructive pulmonary disease; and\n\n(b) if that exposure has ceased, the clinical onset of chronic obstructive pulmonary disease has occurred within 20 years of cessation;\n\nNote: dust is defined in the Schedule 1 – Dictionary.\n\n(9) inhaling ambient polluted air as specified:\n\n(a) for a cumulative period of at least 70,000 hours before the clinical onset of chronic obstructive pulmonary disease; and\n\n(b) if that exposure has ceased, the clinical onset of chronic obstructive pulmonary disease has occurred within 20 years of cessation;\n\n Note: ambient polluted air as specified is defined in the Schedule 1 – Dictionary.\n\n(10) having infection with human immunodeficiency virus before the clinical onset of chronic obstructive pulmonary disease;\n\n(11) having pulmonary tuberculosis at least 1 year before the clinical onset of chronic obstructive pulmonary disease;\n\nNote: pulmonary tuberculosis is defined in the Schedule 1 – Dictionary.\n\n(12) having alpha-1 antitrypsin deficiency at the time of the clinical onset of chronic obstructive pulmonary disease;\n\n(13) having asthma before the clinical onset of chronic obstructive pulmonary disease;\n\n(14) having bronchiectasis before the clinical onset of chronic obstructive pulmonary disease;\n\n(15) having smoked tobacco products:\n\n(a) in an amount of at least 1 pack-year before the clinical worsening of chronic obstructive pulmonary disease; and\n\n(b) if smoking has ceased before the clinical worsening of chronic obstructive pulmonary disease, then that worsening occurred within 20 years of cessation;\n\nNote: one pack-year is defined in the Schedule 1 – Dictionary.\n\n(16) being exposed to second-hand smoke:\n\n(a) for at least 10,000 hours before the clinical worsening of chronic obstructive pulmonary disease; and\n\n(b) if exposure to second-hand smoke has ceased before the clinical worsening of chronic obstructive pulmonary disease, then that worsening occurred within 20 years of cessation;\n\nNote: being exposed to second-hand smoke is defined in the Schedule 1 – Dictionary.\n\n(17) having smoked cannabis:\n\n(a) in an amount of at least 10 joint-years before the clinical worsening of chronic obstructive pulmonary disease; and\n\n(b) if smoking has ceased before the clinical worsening of chronic obstructive pulmonary disease, then that worsening occurred within 20 years of cessation;\n\nNote: joint-years of cannabis is defined in the Schedule 1 – Dictionary.\n\n(18) inhaling smoke from the combustion of polluting fuels in an enclosed space:\n\n(a) for a cumulative period of at least 5,000 hours before the clinical worsening of chronic obstructive pulmonary disease; and\n\n(b) if that exposure has ceased, the clinical worsening of chronic obstructive pulmonary disease has occurred within 20 years of cessation;\n\nNote: polluting fuels is defined in the Schedule 1 – Dictionary.\n\n(19) inhaling a respiratory tract irritant from the specified list of respiratory tract irritants resulting in:\n\n(a) signs and symptoms of severe acute lower respiratory damage requiring medical attention within 48 hours after exposure; and\n\n(b) the persistence of respiratory symptoms and signs for at least one week after exposure, within the 10 years before the clinical worsening of chronic obstructive pulmonary disease;\n\nNote: specified list of respiratory tract irritants is defined in the Schedule 1 – Dictionary.\n\n(20) inhaling vapour, gas, or fumes of a substance from the specified list of substances in an enclosed space:\n\n(a) for a cumulative period of at least 10,000 hours before the clinical worsening of chronic obstructive pulmonary disease; and\n\n(b) if that exposure has ceased, the clinical worsening of chronic obstructive pulmonary disease has occurred within 20 years of cessation;\n\nNote: specified list of substances is defined in the Schedule 1 – Dictionary.\n\n(21) inhaling vapour, gas, or fumes of a substance from the specified list of substances, in an open environment:\n\n(a) for a cumulative period of at least 20 000 hours before the clinical worsening of chronic obstructive pulmonary disease; and\n\n(b) if that exposure has ceased, the clinical worsening of chronic obstructive pulmonary disease has occurred within 20 years of cessation;\n\nNote: specified list of substances is defined in the Schedule 1 – Dictionary.\n\n(22) inhaling organic or inorganic dust at a concentration of greater than 5 milligrams per cubic metre:\n\n(a) for a cumulative period of at least 10,000 hours before the clinical worsening of chronic obstructive pulmonary disease; and\n\n(b) if that exposure has ceased, the clinical worsening of chronic obstructive pulmonary disease has occurred within 20 years of cessation;\n\nNote: dust is defined in the Schedule 1 – Dictionary.\n\n(23) inhaling ambient polluted air as specified:\n\n(a) for a cumulative period of at least 70,000 hours before the clinical worsening of chronic obstructive pulmonary disease; and\n\n(b) if that exposure has ceased, the clinical worsening of chronic obstructive pulmonary disease has occurred within 20 years of cessation;\n\nNote: ambient polluted air as specified is defined in the Schedule 1 – Dictionary.\n\n(24) having infection with human immunodeficiency virus before the clinical worsening of chronic obstructive pulmonary disease;\n\n(25) having at least 2 episodes of acute viral or bacterial lower respiratory tract infection requiring medical treatment within the 1 year before the clinical worsening of chronic obstructive pulmonary disease;\n\nNote: lower respiratory tract is defined in the Schedule 1 – Dictionary.\n\n(26) having pulmonary tuberculosis at least 1 year before the clinical worsening of chronic obstructive pulmonary disease;\n\nNote: pulmonary tuberculosis is defined in the Schedule 1 – Dictionary.\n\n(27) having alpha-1 antitrypsin deficiency at the time of the clinical worsening of chronic obstructive pulmonary disease;\n\n(28) having asthma before the clinical worsening of chronic obstructive pulmonary disease;\n\n(29) having bronchiectasis before the clinical worsening of chronic obstructive pulmonary disease;\n\n(30) having gastro-oesophageal reflux disease, with erosive oesophagitis or oesophageal stricture within 2 years before the clinical worsening of chronic obstructive pulmonary disease;\n\n(31) inability to obtain appropriate clinical management for chronic obstructive pulmonary disease.\n\n10 Relationship to service\n\n(1) The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.\n\n(2) The factors set out in subsections 9(15) to 9(31) apply only to material contribution to, or aggravation of, chronic obstructive pulmonary disease where the person's chronic obstructive pulmonary disease was suffered or contracted before or during (but did not arise out of) the person's relevant service.\n\n11 Factors referring to an injury or disease covered by another Statement of Principles\n\nIn this Statement of Principles:\n\n(1) if a factor referred to in section 9 applies in relation to a person; and\n\n(2) that factor refers to an injury or disease in respect of which a Statement of Principles has been determined under subsection 196B(2) of the VEA;\n\nthen the factors in that Statement of Principles apply in accordance with the terms of that Statement of Principles as in force from time to time.\n\n \n\n \n\nSchedule 1 - Dictionary \n\nNote: See Section 6\n\n1 Definitions\n\nIn this instrument:\n\n ambient polluted air as specified means air with annual average levels of:\n\n(a) particulates with an aerodynamic diameter <2.5 μm (PM2.5) exceeding 30 μg/m3;\n\n(b) particulates with an aerodynamic diameter <10 μm (PM10) exceeding 150 μg/m3;\n\n(c) nitrogen dioxide exceeding 18.0 μg/m3; or\n\n(d) nitrous oxides exceeding 31.5 μg/m3.\n\n being exposed to second-hand smoke means being in an enclosed space and inhaling smoke from burning tobacco products or smoke that has been exhaled by another person who is smoking.\n\n chronic obstructive pulmonary disease—see subsection 7(2).\n\n dust means airborne particulate matter consisting of solid particles of organic or inorganic matter, of aerodynamic diameter between 0.5 and 30 micrometres, excluding wood dust.\n\n joint-years of cannabis means a calculation of consumption where 1 joint-year of cannabis equals 1 joint per day for a period of 1 year.\n\n lower respiratory tract means the trachea, bronchi, and lungs.\n\n MRCA means the Military Rehabilitation and Compensation Act 2004.\n\n one pack-year means the amount of tobacco consumed in smoking 20 cigarettes per day for a period of 1 year, or an equivalent amount of tobacco products.\n\nNote 1: An equivalent amount of tobacco products is 7,300 grams of smoking tobacco by weight, either in cigarettes, pipe tobacco or cigars, or a combination of same. For pipe tobacco, cigars or combinations of multiple tobacco types, 1 gram of tobacco is considered to be equal to one cigarette.\n\nNote 2: Pack-years are calculated by dividing the number of cigarettes smoked per day by 20 and multiplying this number by the number of years the person has smoked. For example, smoking 10 cigarettes per day for 10 years is equal to 5 pack-years, and smoking 40 cigarettes per day for 10 years is equal to 20 pack-years.\n\n persistent airflow limitation is a post-bronchodilator spirometric ratio of forced expiratory volume in one second divided by forced vital capacity (FEV1/FVC) less than 0.7, which is not attributable to other pathology.\n\n polluting fuels means animal dung, wood, charcoal, coal, coke, crop residues, and kerosene.\n\n pulmonary tuberculosis means an active tuberculosis infection that occurs in the lung or respiratory tract in which the tuberculosis bacteria are multiplying and inducing an inflammatory response.\n\n relevant service means:\n\n(a) operational service under the VEA;\n\n(b) peacekeeping service under the VEA;\n\n(c) hazardous service under the VEA;\n\n(d) British nuclear test defence service under the VEA;\n\n(e) warlike service under the MRCA; or\n\n(f) non-warlike service under the MRCA.\n\nNote: MRCA and VEA are also defined in the Schedule 1 - Dictionary.\n\n specified list of respiratory tract irritants means:\n\n(a) ammonia;\n\n(b) chlorine;\n\n(c) dust at a concentration of greater than five milligrams per cubic metre;\n\n(d) Lewisite;\n\n(e) oxides of nitrogen;\n\n(f) oxides of sulphur;\n\n(g) phosgene;\n\n(h) phthalic anhydride;\n\n(i) smoke from fires;\n\n(j) sulphur mustard (mustard gas); or\n\n(k) another respirable agent which causes comparable tissue damage. \n\nNote: dust is also defined in the Schedule 1 – Dictionary.\n\n specified list of substances means:\n\n(a) ammonia gas at a concentration >0.1 ppm; \n\n(b) cadmium fumes at a concentration >0.00001 mg/m3;\n\n(c) chlorine dioxide gas at a concentration >0.001 ppm;\n\n(d) chlorine gas at a concentration >0.00005 ppm;\n\n(e) cleaning agents during cleaning;\n\n(f) diesel engine exhaust;\n\n(g) insecticides at the time of application;\n\n(h) herbicide at the time of application;\n\n(i) methylenediphenyl diisocyanate >0.00001 ppm;\n\n(j) phthalic anhydride;\n\n(k) sulphur dioxide gas at a concentration >0.1 ppm;\n\n(l) sulphur mustard (mustard gas);\n\n(m) toluene diisocyanate at a concentration >0.000003 ppm; or\n\n(n) welding materials during welding.\n\n \n\n terminal event means the proximate or ultimate cause of death and includes the following:\n\n(a) pneumonia;\n\n(b) respiratory failure;\n\n(c) cardiac arrest;\n\n(d) circulatory failure; or\n\n(e) cessation of brain function.\n\n VEA means the Veterans' Entitlements Act 1986.\n\n \n","sortOrder":0}],"analysis":{"flash_summary":{"complexity_score":6,"scope_assessment":{"changed":true,"description":"This 2023 Statement of Principles replaces the 2014 SOP (section 4) and alters scope in several concrete ways: it provides more granular, quantitative exposure thresholds (e.g. explicit cumulative hours for second‑hand smoke, vapours/gases, dust and ambient pollutant concentration cut‑offs in the Schedule), it expressly includes cannabis smoking (joint‑years), and it lists additional clinical and contextual contributors (HIV infection, gastro‑oesophageal reflux disease within 2 years of worsening, inability to obtain appropriate clinical management). These additions and the numeric definitions make the pathways to entitlement more specific than in many older SOPs, expanding and/or clarifying the set of accepted exposures while simultaneously narrowing outcomes to those meeting precise thresholds. The change therefore both broadens the range of recognised causal factors (e.g. cannabis, precise pollutant metrics) and increases the evidentiary precision required to meet the SOP, which materially changes how claimants and decision‑makers will establish service‑relatedness."},"complexity_factors":["Large number of discrete, conditional factors (31 listed scenarios in section 9, many with multiple sub-conditions).","Detailed numeric thresholds in the Schedule (pack‑years, joint‑years, cumulative exposure hours, PM2.5/PM10 and gas concentration cut-offs).","Multiple defined technical terms in Schedule 1 (e.g. ambient polluted air as specified; persistent airflow limitation; specified list of substances; specified list of respiratory tract irritants).","Cross-references to other statutory instruments and SOPs (section 11; references to VEA and MRCA).","Separate treatment for onset vs clinical worsening (sections 9(1)–9(14) vs 9(15)–9(31)) with different threshold values and relation-to-service limits (section 10).","Exclusions list narrowing medical scope (section 7(2)(c)).","Time‑limit conditions tied to cessation of exposure (20 years for many exposures) and short windows for acute irritant effects (48 hours/one week) create nested temporal rules.","Measurement and evidentiary requirements implied by numeric thresholds increase interpretative complexity for decision‑makers and claimants.","Repeal and replacement of the 2014 SOP requires comparison to prior text for continuity (section 4)."],"plain_english_summary":"**What this instrument does (mechanics)**\n\n- This is a Statement of Principles (SOP) produced by the Repatriation Medical Authority for use in veterans’ entitlement and military compensation claims. It sets out the medical definition of chronic obstructive pulmonary disease (COPD) and a list of specific, measurable factors that, if shown to exist and to be related to a person’s relevant service, are sufficient to raise a “reasonable hypothesis” that the COPD (or death from COPD) is related to that service (see sections 7, 8 and 9).\n\n- The SOP replaces the 2014 version (section 4) and commences on 27 March 2023 (section 2). It applies where a claim is made under the Veterans’ Entitlements Act 1986 or the Military Rehabilitation and Compensation Act 2004 (section 5).\n\n- The SOP gives a working definition of COPD (including chronic bronchitis, emphysema and persistent airflow limitation) and a list of excluded respiratory conditions (section 7(2)). It also confirms that death is included if COPD contributed to the terminal event (section 7(5)).\n\n- Section 9 lists the specific factors — any one of which, when shown and connected to relevant service, is enough to raise the required reasonable hypothesis. Those factors are expressed as measurable thresholds or clinical conditions (for example: minimum pack‑years of smoking, minimum cumulative hours of exposure to second‑hand smoke or vapours/gases, specified concentrations for particular gases, documented prior infections such as pulmonary tuberculosis, alpha‑1 antitrypsin deficiency, asthma or bronchiectasis prior to onset, etc.). The Schedule (dictionary) provides precise definitions and numerical thresholds (for example, what constitutes one “pack‑year”, “joint‑years”, PM2.5/PM10 thresholds, and concentrations for specific gases).\n\n- Section 10 requires that any factor relied on must be related to the veteran’s “relevant service” (the types of service covered are defined in the dictionary). Subsections 9(15)–9(31) are limited to cases of material contribution to, or aggravation of, COPD where the disease pre‑existed or was contracted before/during (but not arising out of) relevant service.\n\n- Section 11 makes clear that where a listed factor refers to another injury or disease that itself has an SOP, that related SOP applies in the terms it is in force (i.e. cross‑reference to other SOPs).\n\n**Who this affects**\n\n- Primary affected parties: veterans and former members making claims under the VEA or MRCA, and their dependants where death is claimed (sections 5, 7(5)).\n- Administrative/decision actors: Repatriation Medical Authority (sets SOP), claims assessors at the Department of Veterans’ Affairs (use the SOP), treating clinicians (who must supply medical and exposure evidence), and tribunal/appeal bodies when disputes arise.\n\n**Why this matters (purpose statements and practical consequence)**\n\n- The RMA states it has medical‑scientific evidence connecting COPD to relevant service (section 8). The SOP operationalises that position by listing quantifiable exposures and clinical conditions that, when shown and tied to service, will meet the “reasonable hypothesis” threshold needed to progress an entitlement claim (section 9).\n\n- Mechanically, the SOP converts a broad medical association into a closed set of evidentiary pathways: establish one of the listed factors (using the numerical/clinical tests in the Schedule), and show it relates to relevant service; that is sufficient to satisfy the initial threshold for the claim to proceed.\n\n**Costs, incentives, trade‑offs and implementation considerations**\n\n- Who pays: benefits awarded following a successful claim are paid by the Department of Veterans’ Affairs (the public payer). Administrative costs of assessing claims (medical review, evidence gathering) are borne by the department.\n\n- Who decides and where discretion sits: the RMA sets the SOP (statutory), but claims officers and medical assessors decide whether a veteran has demonstrated the required factor(s) and the relationship to relevant service (sections 8, 10). Cross‑references to other SOPs (section 11) can add interpretative complexity.\n\n- Evidence and compliance burden on claimants: the SOP applies precise numeric thresholds (e.g. pack‑years, joint‑years, cumulative exposure hours, pollutant concentrations). Claimants must provide medical records, occupational/exposure histories, or other contemporaneous evidence sufficient to meet those thresholds. Historical exposures (hours of exposure, ambient pollutant levels at past locations) may be difficult to document, increasing evidence‑gathering costs and the chance of rejection based on lack of documentation.\n\n- Binary/threshold effects and substitution: the use of specific numerical cut‑offs creates binary outcomes (met/not met). That concentrates benefits on claimants who can document exposures above thresholds and imposes an evidentiary penalty on those with similar but undocumented or marginally lower exposures.\n\n- Administrative and implementation risk: assessing cumulative exposure hours and historical pollutant concentrations requires specialist assessment. There is a risk of inconsistent decision‑making unless assessors apply standard methods. Cross‑referenced SOPs may require consolidation of evidence across multiple disease statements.\n\n- Opportunity costs: time and administrative resources spent establishing marginal or borderline exposures could divert capacity from other claim areas.\n\n- Effects on private enterprise, competition and prices: the SOP operates within the veterans’ compensation system and does not directly regulate private firms, markets, or prices. Indirect effects may occur where documented workplace exposure histories (from employers, medical surveillance records) are used in claims; employers’ record‑keeping could influence claim outcomes, but the SOP does not create direct regulatory obligations on private parties.\n\n**Concrete trade‑offs in the instrument**\n\n- Precision vs accessibility: precise definitions and thresholds improve predictability for assessors but raise the bar for claimants who lack documentary evidence.\n\n- Scope clarity vs medical nuance: the SOP excludes several respiratory conditions explicitly (section 7(2)(c)), which narrows the class of accepted claims compared with a less specified medical definition; at the same time it recognises multiple pathways (smoking, pollutants, infections, genetic deficiency) that can lead to COPD.\n\n**Net operational effect**\n\n- The SOP turns medical judgement into a rule‑based gateway for entitlement: establish a listed factor (with supporting evidence), and, if that factor is related to relevant service, the claim reaches the reasonable hypothesis threshold (sections 8–10). That simplifies initial claim triage but shifts burden to claimants to produce exposure and medical evidence matching the Schedule’s numeric and clinical definitions."},"flash_summary_failed":{"failed":true,"reason":"A positive credit balance is required for all requests, including BYOK, so fallback providers remain available. Add credits at https://vercel.com/d?to=%2F%5Bteam%5D%2F%7E%2Fai%3Fmodal%3Dtop-up to continue.","source":"analysis-cron"},"kimi_summary":{"content_quality":"ok","complexity_score":6,"scope_assessment":{"changed":false,"description":"This instrument maintains the established scope of Statements of Principles under the Veterans' Entitlements Act 1986. It is a direct replacement of the 2014 version (No. 37 of 2014) concerning the same condition (COPD). While the specific factors and thresholds have been updated based on new medical-scientific evidence, the fundamental purpose — establishing reasonable hypothesis factors for veterans' compensation claims — remains unchanged. The structure of having onset factors (1-14) and worsening factors (15-31) follows the standard template for these instruments."},"complexity_factors":["31 distinct factors with multiple sub-paragraphs (a) and (b) containing cumulative thresholds and temporal conditions","14 defined terms in Schedule 1, many with nested technical definitions (e.g., 'one pack-year' with mathematical calculation notes)","Extensive cross-referencing between sections — factors in section 9 repeatedly refer to definitions in Schedule 1","Dual structure: factors 1-14 for 'clinical onset' and factors 15-31 for 'clinical worsening', creating parallel but slightly different regimes","Precise quantitative thresholds throughout: 5 pack-years vs 1 pack-year, 5,000/10,000/20,000/70,000 hours, 5 mg/m³ concentrations, 20-year cessation windows","Conditional logic with temporal limitations ('if exposure has ceased...within 20 years')","Incorporation by reference to ICD-10-AM medical coding system (Tenth Edition, 2017)","Interaction clause in section 11 creating dynamic links to other Statements of Principles","Specific exclusion list in section 7(2)(c) requiring careful differential diagnosis (7 excluded conditions)"],"plain_english_summary":"This instrument tells when COPD (including chronic bronchitis and emphysema) can be accepted as service-related for veterans’ compensation. The Repatriation Medical Authority lists 31 risk factors — if a veteran has at least one linked to their service, that can meet the \"reasonable hypothesis\" test, easing claims for ADF members and veterans under the Veterans’ Entitlements Act and MRCA. It updates 2014 science, sets exposure thresholds and a typical 20‑year cut‑off, giving clearer claim standards."}},"importantCases":[],"_links":{"self":"/api/acts/statement-of-principles-concerning-chronic-obstructive-pulmonary-disease-reasonable-hypothesis-no-17","history":"/api/acts/statement-of-principles-concerning-chronic-obstructive-pulmonary-disease-reasonable-hypothesis-no-17/history","analysis":"/api/acts/statement-of-principles-concerning-chronic-obstructive-pulmonary-disease-reasonable-hypothesis-no-17/analysis","conflicts":"/api/acts/statement-of-principles-concerning-chronic-obstructive-pulmonary-disease-reasonable-hypothesis-no-17/conflicts","importantCases":"/api/acts/statement-of-principles-concerning-chronic-obstructive-pulmonary-disease-reasonable-hypothesis-no-17/important-cases","documents":"/api/acts/statement-of-principles-concerning-chronic-obstructive-pulmonary-disease-reasonable-hypothesis-no-17/documents"}}